Suraksha Diagnostic
281.95
+1.75(+0.62%)
Market Cap₹1,468.42 Cr
PE Ratio50.33
Company Performance:
1D+0.62%
1M-13.19%
6M-15.25%
1Y-32.43%
5Y-32.43%
View Company Insightsright
More news about Suraksha Diagnostic
09Apr 25
Suraksha Diagnostic Completes Acquisition of 63% Stake in Fetomat Wellness
Suraksha Diagnostic Limited has completed the acquisition of a 63% equity stake in Fetomat Wellness Private Limited for a total investment not exceeding ₹5.19 crore. This strategic move makes Fetomat Wellness a subsidiary of Suraksha, expanding its portfolio and operational reach in the healthcare sector. The acquisition aligns with Suraksha's previously announced plans and is expected to enhance its service offerings and technological capabilities in the wellness space.
28Mar 25
Suraksha Diagnostic Expands into Fetal Medicine with ₹51.9 Crore Investment in Fetomat
Suraksha Diagnostic Limited is investing ₹51.9 crore to acquire a 63% stake in Fetomat Wellness Private Limited, a network of fertility and pregnancy care clinics. The acquisition involves subscribing to new equity shares and purchasing existing shares. Fetomat specializes in fetal and maternal medicine, offering services like pregnancy care, prenatal diagnosis, and genetic counseling. This strategic move allows Suraksha to expand its service portfolio and strengthen its position in specialized medical services. The deal is expected to close within three months.
27Mar 25
Suraksha Diagnostic Expands into Fetal Medicine with Strategic Investment in Fetomat
Suraksha Diagnostic Limited has approved a strategic investment of up to ₹5.19 crore in Fetomat Wellness Private Limited, acquiring a 63% stake. The investment will be made through a combination of new equity shares subscription and purchase of existing shares. Fetomat specializes in fetal and maternal medicine, offering services like pregnancy care, prenatal diagnosis, and genetic counseling. This acquisition marks Suraksha's entry into specialized fetal and maternal medicine, expanding its service portfolio. Fetomat has shown significant growth since its incorporation in 2021, with its turnover increasing from ₹0.45 crore in FY 2021-22 to ₹4.11 crore in FY 2023-24.
Suraksha Diagnostic
281.95
+1.75
(+0.62%)
1 Year Returns:-32.43%
Industry Peers
Dr. Lal Path Labs
2,998.40
(-1.82%)
Vijaya Diagnostic Centre
1,038.10
(-3.88%)
Metropolis Healthcare
1,924.70
(-0.33%)
Krsnaa Diagnostics
760.50
(+0.61%)
Suraksha Diagnostic
281.95
(+0.62%)
3B BlackBio DX
1,266.40
(-0.93%)
Sastasundar Ventures
310.00
(-1.37%)
Chandan Healthcare
325.00
(+1.21%)